The update follows a European review of clinical evidence, post-authorisation reports and published literature, which concluded that semaglutide use in adults with type 2 diabetes may be associated with an approximately two-fold increase in the relative risk of developing NAION
The little capybara widget is a great visual to help me know what my body needs. This app does exactly what I needed with tracking shots location, time, amount, current medication level, and reminders for the next one
Easy Nutrition Guide to Lose Weight on Semaglutide A Patient-Ready Resource for Wegovy and Ozempic Users (Updated for 2026) Give your patients clear, practical nutrition guidance they can actually follow while on GLP-1 medications
GLP-1 medications can be an effective tool for weight loss but require close monitoring and a multidisciplinary approach
HMA-IR, homeostatic model assessment for insulin resistance